Integra LifeSciences Holdings Corporation

$IART - Nasdaq - Healthcare Equipment/Supplies
0 LAST
0 CHANGE $
0 CHANGE %
loader
ON 0
WATCHLISTS

COMMUNIQUÉ DETAILS

Up 0 0 Down
Integra LifeSciences Announces Three-Year Contract With Premier Healthcare Alliance

PLAINSBORO, N.J., Jan. 31, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it was awarded a three-year group purchasing agreement with the Premier healthcare alliance, one of the largest group purchasing organizations in the United States. The agreement includes Jarit® surgical and laparoscopic instruments, Ruggles®- Redmond™ neuro/spine instruments, Padgett® reconstructive and plastic surgery instruments and sterilization containers.

Dan Reuvers, Integra's President, Surgical Instruments said: "We are very pleased that Premier has selected Integra as a contracted supplier for our instruments and sterilization containers. This complements another agreement we signed with Premier in 2012 for our award-winning Luxtec® LED Surgical Headlight System, intended to limit uncertainty by ensuring their membership has access to our broad portfolio of quality products."

Integra is a leading provider of surgical instruments used in virtually all surgical disciplines at more than 5,200 hospitals and surgery centers worldwide, and is also one of the world's largest suppliers of surgical headlight systems, which are used by over 60,000 surgeons, worldwide. Its Luxtec® LED Surgical Headlight System, which was awarded 1st place in the "Capital Equipment" category of Surgical Products magazine's 2012 "Excellence in Surgical Products Awards" (ESP Awards), is designed to deliver the cool brightness and color surgeons need for visibility, along with increased mobility in the operating room. 

In addition to Integra's Jarit®, Ruggles®- Redmond™, Luxtec® and  Padgett® products, the company also produces the Omni-Tract® family of retractor systems, and Integra® Miltex® surgical, dental and veterinary instruments.

About Integra

Integra LifeSciences, a world leader in medical devices, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedics, neurosurgery, spine, reconstructive and general surgery. For more information, please visit www.integralife.com

The Integra LifeSciences Holdings Corp. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=440

About the Premier healthcare alliance

Premier is a performance improvement alliance of more than 2,700 U.S. hospitals and 90,000 other sites using the power of collaboration and technology to lead the transformation to coordinated, high-quality, cost-effective care. Owned by hospitals, health systems and other providers, Premier operates a leading healthcare purchasing network with more than $4 billion in annual savings. Premier also maintains the nation's largest clinical, financial and outcomes database with information on 1 in 4 patient discharges. A world leader in delivering measurable improvements in care, Premier works with the Centers for Medicare & Medicaid Services. Headquartered in Charlotte, N.C., Premier also has an office in Washington. http://www.premierinc.com.

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements concerning the products and services provided by Integra. Such forward looking statements involve risks and uncertainties that could cause actual results to differ materially from predicted or expected results. Among other things, the willingness of surgical professionals to use Integra products may affect the prospects for their use in surgical procedures. In addition, the economic, competitive, governmental, technological and other factors, identified under the heading "Risk Factors" included in Item IA of Integra's Annual Report on Form 10-K for the year ended December 31, 2011 and information contained in subsequent filings with the Securities and Exchange Commission could affect actual results.

CONTACT: Integra LifeSciences Holdings Corporation
         Gianna Sabella
         Director, Corporate Communications
         (609) 936-2389
         gianna.sabella@integralife.com

Source: Integra LifeSciences Holdings Corp.
SHARE THIS: Twitter StockTwits LinkedIn Google Plus SHORT URL: http://bdvt.co/meZ

SIGN IN TO BOARDVOTE

FORGOT PASSWORD?